Sumitomo Pharma America, INC. (Formerly Sunovion Pharmaceuticals INC.)
Based in MA
🤖
AI Overview
With $7.5M in lobbying spend across 25 quarterly filings, Sumitomo Pharma America, INC. (Formerly Sunovion Pharmaceuticals INC.) is one of the biggest lobbying spenders in Washington. Their lobbying covers 1 issue area. Active from 2018 to 2024.
$7.5M
Total Spend
7
Years Active
1
Firms Hired
3
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $1.3M |
| 2019 | $1.3M |
| 2020 | $1.1M |
| 2021 | $1.1M |
| 2022 | $1.3M |
| 2023 | $1.1M |
| 2024 | $210K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
- •Discussions regarding protected classes reform
- •Part D proposed rule and LIS co-pays
- •Part B Payment reform
- •Massachusetts 1115 Medicaid waiver amendment
- •FDA Regulatory Review
- •Opioid Substance Abuse legi
- •Discussions regarding protected classes reform
- •Part B drug coverage and Payment reform
- •Massachusetts 1115 Medicaid waiver amendment
- •FDA Regulatory Review
- •Opioid Substance Abuse legislation
- •Medicare Pa
- •Discussions regarding protected classes reform, Medicare Part D
- •Part B drug coverage and Payment reform
- •Opioid Substance Abuse legislation
- •Medicare Part D Coverage Gap provisions in Bipartisan Budget
- •Discussions regarding protected classes reform, Medicare Part D
- •Part B drug coverage and Payment reform; international pricing index model
- •Medicare Part D Coverage Gap provisions in Bipartisan Budget
- •Discussions regarding protected classes reform, Medicare Part D
- •Part B drug coverage and Payment reform; international pricing index model
- •Medicare Part D Negotiation/Non-Interference Repeal Bills
- •Pri
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.